Cerebral Oximetry Monitoring Market Size - By Application, By Age Group, By End Use - Global Forecast, 2025 - 2034

Cerebral Oximetry Monitoring Market Size

The global cerebral oximetry monitoring market was valued at USD 239.4 million in 2024 and is set to grow at a CAGR of 6.7% from 2025 to 2034.  This incremental growth rate is owing to the increasing prevalence of neurological ailments, coupled with an increasing number of surgeries globally. Growing awareness regarding patient safety and cerebral desaturation associated with the rising demand for non-invasive brain monitoring systems and technological advancements among others is anticipated to drive the market growth. The cerebral oximetry monitoring industry is witnessing significant growth in recent years owing to factors such as an ageing population, technological advancements, and enhanced patient safety, among others.
 

The growing elderly population, as well as an increase in the number of ailments such as cardiovascular and neurological problems, are important drivers of cerebral oximetry monitoring market growth. According to the Centers for Disease Control and Prevention (CDC), approximately 697,000 persons in the U.S. developed coronary artery disease (CAD) in 2021 as a result of adopting a western lifestyle that included heavy smoking, alcohol consumption, and physical inactivity. The CDC also stated that heart disease is the leading cause of death in the U.S. One person dies every 33 seconds from cardiovascular disease.
 

In 2022, 702,880 people died from heart disease. That's the equivalent of 1 in every 5 deaths. This increasing number of CAD cases and even heart diseases is expected to drive up demand for cerebral oximetry monitoring devices used in CAD surgery to ensure patient safety.
 

It has also been noticed that regulatory authorities such as the FDA and the EMA approve new cerebral oximeter devices, presenting an opportunity for cerebral oximetry monitoring market participants. Furthermore, the growing prevalence of neurological illnesses increases the demand for cerebral oximeters, which are one of the most essential instruments used to monitor the level of oxygen in the brain. As a result, the increased use of these devices, as well as the ever-changing device industry, are expected to fuel market expansion over the forecast period.
 

Cerebral oximetry monitoring is a medical technology that measures the oxygen saturation levels in the brain. It is a non-invasive method that helps to assess the adequacy of oxygen carried by hemoglobin in the cerebral tissues of the brain.
 

Cerebral Oximetry Monitoring Market Trends

The market for cerebral oximetry monitoring is predicted to increase steadily over the forecast period. This is mostly due to the increasing prevalence of neurological illnesses and the widespread use of cerebral oximeters in developed economies such as North America and Europe.
 

• According to an article released in April 2022 by the National Center for Biotechnology Information (NCBI), hypoxic-ischemic encephalopathy (HIE) affects one to six per 1,000 live births in industrialized countries and 26 per 1,000 live births in poor countries. The increased prevalence of such neurological illnesses fuels demand for cerebral somatic oximeters, which detect oxygen levels in the brain, hence driving cerebral oximetry monitoring market expansion.
   
• In addition, cerebral oximetry is commonly employed in some neonatal intensive care units (NICUs). For instance, according to a paper published in Frontiers in Pediatrics in April 2022, cerebral oximetry is employed in the context of cardiac surgery and is widely used as a clinical routine in the perioperative care of newborn infants with congenital heart disease and neonatology.
   
• According to the publication, a clinical trial is now being conducted in the neonatal section to determine the significance of cerebral oximetry in severe brain injury. During the projected period, increasing research studies are expected to drive the use of cerebral oximetry monitoring in the detection of oxygen levels in various brain and cardiac illnesses.
   
• As a result of the aforementioned reasons, such as the increased prevalence of neurological illnesses and technologically sophisticated product approvals, the cerebral somatic oximeters market is expected to develop over the forecast period. However, the device's high cost due to the pricey sensors used in cerebral oximeters is expected to limit market expansion.
   

Trump Administration Tariffs

• The U.S.-China trade tensions will likely impose future tariff policies, which may aggravate the price of imported parts and devices, in turn, raising the cost of cerebral oximetry monitoring, especially in the U.S. market.
   
• In order to sidestep some of these costs, manufacturers may shift production or assembly work to countries that do not impose tariffs. These moves might influence lead time along with the overall product availability.
   
• Some of these costs could be transferred to the end users, making it more difficult for hospitals and clinics to adhere to budgets, particularly in sensitive areas.
   
• In contrast, the developed countries could stimulate local innovation and the manufacturing of mapping systems and components due to the lack of other options.
   

Cerebral Oximetry Monitoring Market Analysis

Based on application, the market is segmented as cardiac surgery, vascular surgery, and other applications. By 2034, the cardiac surgery segment is expected to grow at a CAGR of 6.6% and is likely to exceed USD 238.2 million. Additionally, the global market for cerebral oximetry monitoring was valued at USD 222.6 million in 2023.
 

• Oximeters have found an application in heart surgeries for monitoring the brain's oxygen levels. For instance, the National Heart, Lung, and Blood Institute states, There are over two million open heart operations conducted worldwide every year due to various cardiac ailments. Hence, more surgical treatment of heart ailments is anticipated to increase the need for cerebral oximetry devices during the forecasted period.
   
• Moreover, when a physician performs a surgical procedure on the heart with the aid of a heart-lung machine, the likelihood of oxygen deprivation to the brain due to altered perfusion is greater. Here, monitoring oxygen levels becomes essential in ensuring how much oxygen is delivered to the brain during the surgical procedure.
   
• Oxygen deprivation could lead to irreversible consequences to the brain, which readily responds to medical interventions. To illustrate, NCBI states that there are around 400,000 heart bypass surgeries done annually in North America, and this figure is predicted to rise. This enables the prevention of serious life-threatening complications after surgery, such as brain injury, vascular injury, or dementia.
   
• In both mild and advanced countries, heart diseases such as heart failure and heart attacks remain the worst health threats, surpassing any other illness for mortality and morbidity. Similarly, the number of patients requiring heart surgery increases on its own as more people suffer from heart diseases. 
   
• There is an increasing demand for devices capable of safeguarding the brain during these procedures. Furthermore, the increasing prevalence of heart disease, alongside technological advancements and stricter patient safety regulations, elucidates why brain oxygen monitoring systems are increasingly essential in cardiac surgeries.
   

Based on age group, the cerebral oximetry monitoring market is bifurcated as adult and pediatric. The adult segment is projected to grow at a 6.4% CAGR, reaching over USD 290.7 million by 2034.
 

• A growing global population has led to a higher occurrence of age-related problems such as cardiovascular diseases, neurodegenerative disorders, and other medical conditions that may require surgery. In such circumstances, cerebral oximetry monitoring is a crucial device to guarantee sufficient brain oxygenation during the procedure.
   
• The growing acceptance and clearance of new devices to monitor cerebral oxygen levels in adults is another major element driving demand for devices. For example, in August 2021, Masimo got FDA approval to enhance its "O3 Regional Oximetry" technology to monitor somatic tissue oxygenation saturation and compare oxyhaemoglobin, hemoglobin, and deoxyhaemoglobin levels in adult brains.
   
• With this clearance, O3 can now be used for cerebral and somatic purposes in US patient groups and is CE-marked in many countries. The increased usage of O3 technology will benefit patient care by allowing doctors to more properly monitor oxygenation levels.
   

Based on end use, the cerebral oximetry monitoring market is classified into hospitals, ambulatory surgical centers, and other end users. The hospitals segment dominated the market with a revenue share of 48.7% in 2024.
 

• Like any other advanced facility, hospitals have integrated cerebral oximetry monitoring for a variety of reasons, such as patient safety, neurological impairment, and quality of care. Patients are increasingly favoring hospitals that employ sophisticated monitoring equipment, especially during high-risk procedures and surgeries. Such medical facilities need not worry about attracting patients because those already equipped with cerebral oximetry monitoring devices are able to fulfill the demands of complex surgeries and critical care medicine. In addition, patients who are getting further advanced treatments tend to shift towards oximetry provided by hospitals.
   
• Most people go to hospitals and clinics because they have access to specialists and facilities for performing heart-related surgeries.
   
• Brain oximeters are mostly utilized in hospital operating rooms and intensive care units to monitor patients' brain desaturation levels. Thus, rising hospital and clinic visits are likely to fuel market expansion. 
   

U.S. cerebral oximetry monitoring market size crossed USD 85.5 million and 91.3 million in 2023 and 2024, respectively. Moreover, the market is anticipated to grow at a CAGR of 5.9% between 2025 and 2034.
 

• The U.S. is anticipated to have a sizable market share because of elements like the growing number of elderly people, the increased prevalence of neurological disorders, improved healthcare facilities, and the robust presence of industry players in the area.
   
• According to data updated by Cedars-Sinai in January 2022, the most common heart surgery is coronary artery bypass graft surgery (CABG), also referred to as coronary artery bypass or bypass surgery. In the U.S., over 300,000 people undergo successful bypass surgery annually.
   
• Therefore, it is anticipated that the high prevalence of CABG procedures in the U.S. will increase the usefulness of cerebral somatic oximeters and open up new avenues for the development of technologically sophisticated products, which will fuel the market's expansion.
   
• In addition, the Alzheimer's Association reports that the number of Americans with Alzheimer's disease is rising quickly. According to data from alzheimers.org, 6.2 million Americans 65 and older were estimated to have Alzheimer-related dementia in the U.S. in 2022. As a result, the high prevalence of neurological disorders in the area is anticipated to fuel the development of cerebral somatic oximeters, which measure the brain's oxygen levels and are anticipated to drive market expansion.
   
• Furthermore, according to the 2022 update of the National Institutes of Health's (NIH) Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC), research expenditures in the U.S. for cerebral palsy were USD 30 million in 2021 and were projected to reach USD 32 million in 2022. For routine oxygen level monitoring in these conditions, cerebral oximeters are frequently utilized.
   
• High disease research expenditures are anticipated to generate chances for the development of novel cerebral somatic oximeters, which will accelerate regional market expansion over the course of the forecast period. As a result, the market under study is anticipated to grow significantly in the region due to all of the previously mentioned factors.
   

In the Europe cerebral oximetry monitoring market, UK is projected to grow remarkably share of in the coming years.
 

• Because of the availability of reimbursement and coverage policies in many countries, as well as healthcare professionals' growing awareness of the benefits, the use of cerebral oximetry monitoring devices is increasing in the UK.
   
• Manufacturers' new technology has improved patient comfort, accuracy, and usability. In March 2022, Masimo declared that its flagship Masimo O3 Regional Oximetry product line would be available throughout Europe, including the UK. The product line includes a new single-patient sticky sensor that improves accuracy and usability for physicians.
   
• There are significant differences in how cerebral oximetry monitoring systems are used in different European countries. For example, cerebral oximetry monitoring is frequently used during pediatric heart surgery in the UK, though it may be less common in other countries.
   
• The UK Neonatal Clinical Network recommends the use of cerebral oximetry monitoring in critical care and newborn surgery. Non-invasive cerebral oximetry monitoring devices are becoming more widely available in this nation.
   

China holds a dominant position in the Asia Pacific cerebral oximetry monitoring market.
 

• Increasing healthcare costs, an increase in surgeries, and an aging population are the main factors driving the market in this nation. Because of China's aging population and rising prevalence of neurological disorders, there is a growing need for cerebral oximetry monitoring technologies in isolated rural areas with limited healthcare resources.
   
• One of the main government initiatives for China's cerebral oximetry monitoring sector is the "Healthy China 2020" plan. The National Health and Family Planning Commission started this program. The goal of this strategy is to use medical technology and equipment, like cerebral oximetry monitoring, to improve the country's healthcare outcomes.
   
• Numerous studies have shown that a high prevalence of comorbid conditions puts older adults at high risk for CVD. In 2021, there were 138 million elderly people in the nation, and that number is predicted to rise to 194 million, according to a report from the National Statistical Office. Furthermore, it is anticipated that by 2050, there will be twice as many people in the world who are 80 years of age or older, totaling over 1.5 billion.
   

Brazil holds a dominant position in the Latin America cerebral oximetry monitoring market.
 

• The integration of cerebral oximetry devices into tertiary hospitals and specialized surgical centers has been made possible by the integration of healthcare modernization techniques and the investment focus placed by the country. 
   
• Brazil’s ever-growing burden of cardiovascular and neurological disorders is increasing the demand for non-invasive monitoring methodologies. Complex cardiac and vascular surgeries now routinely rely on cerebral oximetry to help monitor and improve oxygen perfusion to the brain. With Brazil’s perioperative care and most medical institutions adopting this perioperative care paradigm, this has markedly increased the adoption of cerebral oximetry monitoring. 
   
• Moreover, the country’s position as a leader in the manufacturing and distribution of medical devices in the region has drawn major international ear oximetry companies. Brazil is maintaining its competitive edge in Latin America, as its legislation and policy to innovate within the sector propel development in the oximetry market.
   

Cerebral Oximetry Monitoring Market Share

The top 5 players in the cerebral oximetry monitoring industry account for approximately 55% - 60% of the market. Due to the small number of market participants, the cerebral somatic oximeters market is somewhat consolidated. The main companies have made their names in particular market niches. Additionally, the businesses compete with both established local and international players in developing regions. In order to compete with current products, major players are creating and introducing new technologies and products, while others are purchasing and collaborating with other market-trending businesses. Masimo, Edwards Lifesciences, Medtronic PLC, Nonin Medical Inc., ISS Inc., GE Healthcare Inc., Koninklijke Philips NV, and Mespere LifeSciences are a few of the major participants.
 

Cerebral Oximetry Monitoring Market Companies

Prominent players operating in the cerebral oximetry monitoring industry include:

• CASMED
• Edwards
• GE HealthCare
• HAMAMATSU
• Honeywell
• Masimo
• Medtronic
• Mespere LIFE SCIENCES
• mindray
• NIHON KOHDEN
• NONIN
• sentec
• TERUMO
   

Medtronic provides advanced cerebral oximetry monitoring with real-time analytics, which improves the safety of surgeries. Their INVOS system, using near-infrared spectroscopy (NIRS), is popular in cardiovascular and neurosurgical procedures.
 

Masimo's O3 regional oximetry technology integrates with the Root patient monitoring system, providing continuity of care. This company is well known for its advanced signal processing algorithms that mitigate motion artifacts while increasing accuracy.
 

Edwards Lifesciences merges cerebral oxygen monitoring with hemodynamic management solutions for comprehensive perioperative care. Their ForeSight Elite system provides superior tissue oxygenation in high-risk surgeries.
 

Cerebral Oximetry Monitoring Industry News:

• In March 2022, the FDA expanded its approval of the use of the SedLine brain function monitoring system and sensors by the Medtech company Masimo, which specializes in non-invasive patient monitoring technologies. In the U.S., the system is authorized to be used as a tool for evaluating the efficacy of anesthesia for a patient who is one year old. This approval helped the company to strengthen its product offerings.
   
• In December 2021, Medtronic plc announced that it had received the U.S. FDA 510(k) clearance for its INVOS 7100 cerebral/somatic oximetry system for children. The INVOS system helps to detect key signals to inform time-critical decisions related to hemodynamic management, ventilation, and resuscitation for premature infants, neonates, children, and other patients treated by pediatric clinicians. This approval helped the company to enhance their research and development capabilities, increase their customer base and enhance their business revenue
   

The cerebral oximetry monitoring market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2021 - 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Application

• Cardiac surgery
• Vascular surgery
• Other applications

Market, By Age Group

• Adult
• Pediatric

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE